U.S. drug shortages have reached a decade high and are lasting longer, too

Taking stock of the drug industry, from the lab to the medicine chest

June 4, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | U.S. drug shortages have reached a decade high and are lasting longer, too "Economic pressures... have left our generic medicine supply chain fragile," said Anthony Lakavage of U.S. Pharmacopeia. By Ed Silverman STAT+ | Novartis is flashing warning signs about the fate of its newly acquired myelofibrosis drug It's looking increasingly likely that the $3 billion purchase of MorphoSys to acquire pelabresib has run into serious trouble. By Adam Feuerstein STAT+ | Tracking the FDA advisory panel on MDMA therapy for PTSD FDA advisers weigh the first use of psychedelic therapy for post-traumatic stress disorder, review safety and efficacy data from MDMA trials. By Olivia Goldhill and Meghana Keshavan Carsten Koall/Getty Images Opinion: Outdated Medicare rules prevent some dementia patients from getting the medications they need Medicare has established policies that make it difficult for providers to prescribe appropriate antipsychotic drugs for dementia patients. By Carolyn Clevenger

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser